Gang Wu

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.1K citations

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pharmacology +6

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 662 citations · Full text

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pathology +6

Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells

Kewei Ren, Wenzhe Zhang, Gang Wu et al. · Biomedicine & Pharmacotherapy · 2016 · 102 citations

Oncology, Chemoprevention Strategy, Apoptosis Induction +11

Outcomes With Left Bundle Branch Block and Mildly to Moderately Reduced Left Ventricular Function

Chance M. Witt, Gang Wu, Dachun Yang et al. · JACC Heart Failure · 2016 · 95 citations

Heart Failure, Structural Heart Disease, Cardiovascular Disease +7

Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy

Yuejin Li, Pierre Charles, Changlong Nan et al. · Journal of Molecular and Cellular Cardiology · 2010 · 70 citations · Full text

Diastolic Dysfunction, Cardiac Muscle, Cardiomyopathy +11